BioConsortia raises Series B from Khosla Ventures and Otter Capital

BioConsortia has raised an additional $15 million in Series B funding. Khosla Ventures and Otter Capital participated equally in the round.

ByAngela Sormani

7 April 2014•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs